Browse by author
Lookup NU author(s): Professor John Mathers, Professor John Hesketh
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Evidence is accumulating that individual risk of neoplasia depends on complex interactions among genetic inheritance, a range of exposures both in utero and in postnatal life, and the play of chance. Knowledge of the portfolio of genetic variants that confer susceptibility or resistance to cancer is limited, and there is potential for genome-wide scans and hypothesis-driven studies to reveal novel polymorphisms and haplotypes that modify risk. There is only fragmentary evidence of the scale and nature of diet-gene interactions that modulate risk of neoplasia, but it seems probable that such interactions will play a significant role as they do in other complex diseases including cardiovascular disease and type 2 diabetes. All existing evidence about diet-gene interactions and cancer risk comes from observational studies, and it will be necessary to undertake intervention studies to test the hypotheses generated by epidemiologic investigations. Because it is very unlikely that primary cancer will be an endpoint in dietary intervention studies in the foreseeable future, development of robust surrogate endpoints is a high priority. Emerging biological science using epigenomics, proteomics, and other molecular technologies appears to offer novel approaches to the discovery and validation of surrogate endpoints. © 2007 American Society for Nutrition.
Author(s): Mathers JC, Hesketh JE
Publication type: Conference Proceedings (inc. Abstract)
Publication status: Published
Conference Name: Journal of Nutrition: International Research Conference on Food, Nutrition, and Cancer
Year of Conference: 2007
Pages: 253S-258S
ISSN: 0022-3166
Publisher: American Society for Nutrition
PubMed id: 17182836
Library holdings: Search Newcastle University Library for this item
ISBN: 15416100
